Endometriosis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1)Diagnosed clinically or surgically with endometriosis, accompanied by dysmenorrhea, pelvic pain, or dyspareunia, with a VAS score =3; 2) Diagnosed in traditional Chinese medicine as "qi stagnation and blood stasis syndrome" related to endometriosis-associated pain; 3) Age =18 years, not postmenopausal, with a regular menstrual cycle (21~35 days); 4) Negative urine pregnancy test before enrollment, and contraception during treatment; 5),; 6) Signed informed consent.
Exclusion criteria
Exclusion criteria: 1)Use of sex hormone medications within the past 3 months prior to enrollment; 2) Women with other gynecological diseases, such as post pelvic inflammatory disease sequelae or gynecological malignancies; 3) Lactating women; 4) Patients with severe primary diseases such as cardiovascular, cerebrovascular, liver, kidney, hematopoietic system diseases, or malignant tumors; patients with mental disorders; or those with a history of severe drug allergy or allergy to known drug components; 5) Patients scheduled for surgical treatment or other treatment regimens in the near future; 6) Patients currently participating in or who have participated in other clinical trials within the past 3 months prior to this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| VAS; | — |
Secondary
| Measure | Time frame |
|---|---|
| EHP-5;serum CA125 level;Endometriosis lesion volume; | — |
Countries
China
Contacts
Guangdong Provincial Hospital of Traditional Chinese Medicine